1887

Abstract

Summary

Bacteriophages for and were tested in experimental infections of mice to investigate their potential for the treatment of infections of man. As few as 10 particles of an acinetobacter phage protected mice against 5 LD50 (1 × 10) of a virulent strain of , and phage was demonstrated to have multiplied in the mice. A pseudomonas phage protected mice against 5 LD50 of a virulent strain of , with a PD50 of 1.2 × 10 particles. A staphylococcal phage failed to protect mice infected with a strain of . These studies support the view that bacteriophages could be useful in the treatment of human infections caused by antibiotic-resistant strains of bacteria.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/00222615-37-4-258
1992-10-01
2022-01-18
Loading full text...

Full text loading...

/deliver/fulltext/jmm/37/4/medmicro-37-4-258.html?itemId=/content/journal/jmm/10.1099/00222615-37-4-258&mimeType=html&fmt=ahah

References

  1. Twort F. W. An investigation on the nature of ultra-microscopic viruses. Lancet 1915; 2:1241–1243
    [Google Scholar]
  2. d’Herelle F. Sur un microbe invisible antagoniste des bacillus dysenteriques. Comptes Rendus de L’Academie des Sciences de Paris 1917; 165:373–375
    [Google Scholar]
  3. d’Herelle F. The bacteriophage and its behaviour. (Translation by Smith GH.) Paris: Balliere; 1926
    [Google Scholar]
  4. Boyd J. S. K., Portnoy B. Bacteriophage therapy in bacillary dysentery. Trans R Soc Trop Med Hyg 1944; 37:243–262
    [Google Scholar]
  5. Slopek S., Weber-Dagbrowska B., Dacbrowski M., Kucharewicz-Krukowska A. Results of bacteriophage treatment of suppurative bacterial infections in the years 1981–1986. Arch Immunol Ther Exp (Warsz) 1987; 35:569–583
    [Google Scholar]
  6. Abdul-Hassan H. S., El-Tahan A., Massoud B., Gomaa R. Bacteriophage therapy of pseudomonas burn wound sepsis. Annals of the Mediterranean Burn Club 1990; 3, 4:262–264
    [Google Scholar]
  7. Smith H. W., Huggins M. B. Successful treatment of experimental Escherichia coli infections in mice using phage: its general superiority over antibiotics. J Gen Microbiol 1982; 128:307–318
    [Google Scholar]
  8. Smith H. W., Huggins M. B. Effectiveness of phages in treating experimental Escherichia coli diarrhoea in calves, piglets and lambs. J Gen Microbiol 1983; 129:2659–2675
    [Google Scholar]
  9. Smith H. W., Huggins M. B., Shaw K. M. The control of experi mental Escherichia coli diarrhoea in calves by means of bacteriophages. J Gen Microbiol 1987; 133:1111–1126
    [Google Scholar]
  10. Obana Y., Nishino T., Tanino T. In-vitro and in-vivo activities of antimicrobial agents against Acinetobacter calcoaceticus. J Antimicrob Chemother 1985; 15:441–448
    [Google Scholar]
  11. Adams M. H. Bacteriophages. London: Interscience Publishers; 1959
    [Google Scholar]
  12. Soothill J. S., Lawrence J. C., Ayliffe G. A. J. The efficacy of phages in the prevention of the destruction of pig skin in vitro by Pseudomonas aeruginosa . Med Sci Res 1988; 16:1287–1288
    [Google Scholar]
  13. Soothill J. S., Morton D. B., Ahmad A. The HID50 (hypo thermia–inducing dose 50); an alternative to the LD50 for measurement of bacterial virulence. IntJ Exp Pathol 1992; 73:95–98
    [Google Scholar]
  14. Finney D. J. Probit analysis. 3rd edn Cambridge: Cambridge University Press; 1971203–205
    [Google Scholar]
  15. Asheshov I. N., Wilson J., Topley W. C. The effect of an anti-Vibacteriophage on typhoid infection in mice. Lancet 1937; 1:319–320
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/00222615-37-4-258
Loading
/content/journal/jmm/10.1099/00222615-37-4-258
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error